(Z)-Butylidenephthalide Restores Temozolomide Sensitivity to Temozolomide-Resistant Malignant Glioma Cells by Downregulating Expression of the DNA Repair Enzyme MGMT
Journal: Journal of Pharmacy and Pharmacology (Vol.1, No. 1)Publication Date: 2013-01-15
Authors : Horng-Jyh Harn; Syuan-Rong Chen; Mao-Hsuan Huang; Po-Cheng Lin; Fong-Jia Syu; Dean-Kuo Hsieh; Ssu-Yin Yen; Shinn-Zong Lin; Tzyy-Wen Chiou;
Page : 36-49
Keywords : Z-butylidenephthalide (Bdph); MGMT; temozolomide; GBM; temozolomide-resistant GBM.;
Abstract
Temozolomide, an alkylating agent against high-grade astrocytomas such as GBM (Glioblastoma Multiforme), is the leading compound in a new class of antitumor drugs. Altered methylation by MGMT (O6-methylguanine-DNA-methyltransferase) leads to temozolomide-resistant GBM. Thus, inhibition of MGMT activity is necessary for temozolomide effectiveness. Here we show a synergistic cytotoxic effect on the GBM cell line 8901 with a low dose of (Z)-butylidenephthalide combined with temozolomide. Using CalcuSyn software to analyze the combination index of (Z)-butylidenephthalide and temozolomide, we observed significant synergism in decreasing MGMT expression. We next investigated the effect of (Z)-butylidenephthalide on a temozolomide-resistant cell line GBM22-TMZ and examined changes in MGMT. The combination of 50 μM or 100 μM (Z)-butylidenephthalide with 1,600 μM temozolomide yielded a combination index of 0.649 or 0.581 (an index < 1 indicates synergism), indicating that increasing (Z)-butylidenephthalide enhanced the synergism. In addition, (Z)-butylidenephthalide enhanced MGMT promoter methylation and decreased MGMT expression in a dose-dependent manner. Using a GBM22-TMZ xenograft tumor model, (Z)-butylidenephthalide combined with temozolomide showed significant antitumor effects compared with a single drug. Finally, a survival study with Kaplan-Meier statistical analysis demonstrated a significant benefit of the (Z)-butylidenephthalide/temozolomide combination compared to temozolomide alone. In summary, the combination of (Z)-butylidenephthalide and temozolomide shows potential clinical relevance for treating temozolomide-resistant GBM.
Other Latest Articles
- Development of 166Ho Poly Lactic Acid Microspheres for Radiosynovectomy
- Comparison of the Carbon Nano Tube Field Effect Transistor Based Immunosensor and ELISA for Detecting BRCA1 from Mouse Serum
- Indoleamine-2,3-Dioxygenase Activity in Pulmonary Tuberculosis
- Allosteric Regulation of Dual Function of Thrombin
- Konseptualisasi Omnibus Law dalam Pemindahan Ibukota Negara
Last modified: 2021-04-01 15:06:05